Results 1 - 10 of 32911
Results 1 - 10 of 32911. Search took: 0.051 seconds
|Sort by: date | relevance|
[en] At high radiation doses, breaks in the DNA are considered the critical lesions in initiation of radiation- induced cancer. However, at the very low radiation doses relevant for the general public, the induction of such breaks will be rare, and other changes to the DNA such as DNA methylation may play a role in radiation responses. DNA methylation is the addition of a methyl group to cytosine in the DNA, usually where a cytosine is adjacent to a guanine (CpG). Methylation affects the way in which genes are read, and is inherited from cell to cell on replication. It is known that high dose radiation can cause changes in methylation in the genome but less is known about the effect of low dose radiation on methylation. We developed a sensitive assay to measure the levels of DNA methylation across the mouse genome by analysing a stretch of DNA sequence within Long Interspersed Nuclear Elements-1(LINE1) that comprise a very large proportion of the mouse and human genomes. Using bisulphite modification followed by quantitative real-time polymerase chain reaction (PCP) and high- resolution melt analysis, a very large pool of DNA sequences from throughout the genome can be studied indicating gain or loss of methylation. We validated the assay in vitro using the chemical demethylating agent 5'-aza-2' -deoxycytidine with changes at as few as 3% of CpG's being reproducibly detected. We have demonstrated a difference in the baseline levels of in vivo DNA methylation between male and female mice and between different tissues. Our initial results suggest no significant short-term or long-term changes in global DNA methylation after low dose whole-body X-radiation of 10 -Gy or 10 mGy, with a significant transient increase in DNA methylation observed 1 day after a high dose of 1 Gy. If the low radiation doses tested are inducing changes in global DNA methylation, these would appear to be smaller than the natural variation observed between the sexes and following the general stress of the sham-irradiation procedure itself.
[en] In this work, the properties of the radicals produced in chicken bones have been investigated by ESR technique to determine the amount of dose applied to the chicken meats during the food irradiation. For this goal, the drumsticks from 6-8 weeks old chickens purchased from a local market were irradiated at dose levels of 0; 2; 4; 6; 8 and 10 kGy. Then, the ESR spectra of the powder samples prepared from the bones of the drumsticks have been investigated. Unirradiated chicken bones have been observed to show a weak ESR signal of single line character. CO-2 ionic radicals of axial symmetry with g=1.9973 and g=2.0025 were observed to be produced in irradiated samples which would give rise to a three peaks ESR spectrum. In addition, the signal intensities of the samples were found to depend linearly on the irradiation dose in the dose range of 0-10 kGy. The powder samples prepared from chicken leg bones cleaned from their meats and marrow and irradiated at dose levels of 1, 2, 3, 4, 5, 6, B, 10, 12,14, 16, 1B, 20 and 22 kGy were used to get the dose-response curve. It was found that this curve has biphasic character and that the dose yield was higher in the 12-1B kGy dose range and a decrease appears in this curve over 18 kGy. The radical produced in the bones were found to be the same whether the irradiation was performed after stripping the meat and removing the marrow from the bone or before the stripping. The ESR spectra of both irradiated and non irradiated samples were investigated in the temperature range of 100 K-450 K and changes in the ESR spectra of CO-2 radical have been studied. For non irradiated samples (controls). the signal intensities were found to decrease when the temperature was increased. The same investigation has been carried out for irradiated samples and it was concluded that the signal intensities relative to the peaks of the radical spectrum increase in the temperature range of 100 K-330 K, then they decrease over 330 K. The change in the signal intensity observed over 330 K was found to have an irreversible character. At the end ot five months study, it was found that CO-Zradicals produced in chicken bone were very stable and therefore it was concluded that chicken bone can be used as a dosimetry material. At the end of this work, a simulation procedure has been carried out for irradiated chicken bone ESR spectra to determine the spectral parameters of CO-Z ionic radical. The values obtained for these parameters were found to be in a good agreement with those found in the literature for the same radical. Many samples were irradiated at the same dose level and the ESR spectra were recorded to calculate the errors due to the settlement of the samples in the spectrometer and to the adjustment of the spectrometer. The standard deviations for measured signal intensities were calculated to determine the reliability limits of the numerical results obtained in this work for chicken bone
[en] Purpose: Pulsed reduced-dose-rate radiotherapy (PRDR) is a reirradiation technique that reduces the effective dose rate and increases the treatment time, allowing sublethal damage repair during irradiation. Patients and Methods: A total of 103 patients with recurrent glioma underwent reirradiation using PRDR (86 considered to have Grade 4 at PRDR). PRDR was delivered using a series of 0.2-Gy pulses at 3-min intervals, creating an apparent dose rate of 0.0667 Gy/min to a median dose of 50 Gy (range, 20-60) delivered in 1.8-2.0-Gy fractions. The mean treatment volume was 403.5 ± 189.4 cm3 according to T2-weighted magnetic resonance imaging and a 2-cm margin. Results: For the initial or upgraded Grade 4 cohort (n = 86), the median interval from the first irradiation to PRDR was 14 months. Patients undergoing PRDR within 14 months of the first irradiation (n = 43) had a median survival of 21 weeks. Those treated ≥14 months after radiotherapy had a median survival of 28 weeks (n = 43; p = 0.004 and HR = 1.82 with a 95% CI ranging from 1.25 to 3.10). These data compared favorably to historical data sets, because only 16% of the patients were treated at first relapse (with 46% treated at the second relapse, 32% at the third or fourth relapse, and 4% at the fourth or fifth relapse). The median survival since diagnosis and retreatment was 6.3 years and 11.4 months for low-grade, 4.1 years and 5.6 months for Grade 3, and 1.6 years and 5.1 months for Grade 4 tumors, respectively, according to the initial histologic findings. Multivariate analysis revealed age at the initial diagnosis, initial low-grade disease, and Karnofsky performance score of ≥80 to be significant predictors of survival after initiation of PRDR. Conclusion: PRDR allowed for safe retreatment of larger volumes to high doses with palliative benefit.
[en] Purpose: To establish the magnitude of brachytherapy dose reduction required for stage IIB and III carcinoma cervix patients treated by external radiation and medium dose rate (MDR) brachytherapy at a dose rate of 220±10 cGy/h at point A.Materials and methods: In study-I, at the time of MDR brachytherapy application at a dose rate of 220±10 cGy/h at point A, patients received either 3060 cGy, a 12.5% dose reduction (MDR-12.5), or 2450 cGy, a 30% dose reduction (MDR-30), to point A and they were compared to a group of previously treated LDR patients who received 3500 cGy to point A at a dose rate of 55-65 cGy/h. Study-II was a prospective randomized trial and patients received either 2450 cGy, a 30% dose reduction (MDR-II (30)) or 2800 cGy, a 20% dose reduction (MDR-II (20)), at point A. Patients were evaluated for local control of disease and morbidity. Results: In study-I the 5-year actuarial local control rate in the MDR-30 and MDR-12.5 groups was 71.7±10% and 70.5±10%, respectively, compared to 63.4±10% in the LDR group. However, the actuarial morbidity (all grades) in the MDR-12.5 group was 58.5±14% as against 34.9±9% in the LDR group (P<0.05). Similarly, the grade III and IV morbidity also in the MDR-12.5 group was 12.5±9% as against 5.3±5% in the LDR group (P<0.05). No statistically significant difference in morbidity was seen between the MDR-30 and LDR groups. In study-II the 3-year actuarial local control rate in the MDR-II (30) and MDR-II (20) groups was 66.6±10% and 74.8±9%, respectively. There was a significant correlation between the rectal BED received and the percentage of patients developing rectal morbidity. Only 10% of patients receiving a rectal BED of (100<120) Gy3 developed complication as against 62.5% of those receiving a rectal BED of (140<160) Gy3 (χ2=46.43; P<0.001). Conclusion: We suggest that at a dose rate of 220±10 cGy/h at point A the brachytherapy dose reduction factor should be around 30%, as suggested by radiobiological data, to keep the morbidity as low as possible without compromising the local control rates. (Copyright (c) 1998 Elsevier Science B.V., Amsterdam. All rights reserved.)
[en] On 2nd Apr. 2011, highly contaminated water which flowed into the cable trench of unit 2 brought ambient dose rate up to 1,000mSv/h at the cable pit near the sea water intake of the unit. This was the first sign of the leakage of contaminated water
[en] Ultrasound-guided high-dose-rate prostate brachytherapy (HDR-BT) needle segmentation is performed clinically using live-2D sagittal images. Organ segmentation is then performed using axial images, introducing a source of geometric uncertainty. Sagittally-reconstructed 3D (SR3D) ultrasound enables both needle and organ segmentation, but suffers from shadow artifacts. We present a needle segmentation technique augmenting SR3D with live-2D sagittal images using mechanical probe tracking to mitigate image artifacts and compare it to the clinical standard. Seven prostate cancer patients underwent TRUS-guided HDR-BT during which the clinical and proposed segmentation techniques were completed in parallel using dual ultrasound video outputs. Calibrated needle end-length measurements were used to calculate insertion depth errors (IDEs), and the dosimetric impact of IDEs was evaluated by perturbing clinical treatment plan source positions. The proposed technique provided smaller IDEs than the clinical approach, with mean±SD of −0.3±2.2 mm and −0.5±3.7mm respectively. The proposed and clinical techniques resulted in 84% and 43% of needles with IDEs within ±3mm, and IDE ranges across all needles of [−7.7mm, 5.9mm] and [−9.3mm, 7.7mm] respectively. The proposed and clinical IDEs lead to mean±SD changes in the volume of the prostate receiving the prescription dose of −0.6±0.9% and −2.0±5.3% respectively. The proposed technique provides improved HDR-BT needle segmentation accuracy over the clinical technique leading to decreased dosimetric uncertainty by eliminating the axial-to-sagittal registration, and mitigates the effect of shadow artifacts by incorporating mechanically registered live-2D sagittal images.
[en] This study confirms the interest of the high dose rate brachytherapy, ambulatory technique, well tolerated and comparable in terms of local control rate to the low dose rate technique, whom optimization stands, probably, on the reduction of the time limit in the chronology of therapy seances. (N.C.)
[en] Full text: In many parts of the world, predominantly in Europe, small sized survey meters based on Geiger-Mueller or proportional counters are widely used for dose rate and dose equivalent rate measurements, while in other regions, especially in the U.S., ionisation chambers are preferred for this task. This paper tries to shed some light on the likely reasons for these two diverging instrumental inclinations. Their respective strengths and weaknesses is analyzed in respect to energy response, dose rate measuring range, size, weight and susceptibility to environmental influences. Furthermore the response and limitations regarding the measurement of pulsed radiation (medical X-ray and CT-devices, accelerators, non-destructive testing) is discussed. A newly developed pocket size instrument based on a pan-cake Geiger-Mueller tube is used as an example to explain the capability and flexibility of modern survey meters. The RadEye B20 is a compact multi-purpose dose rate meter and contamination meter for alpha, beta, gamma and X-ray radiation. By virtue of carefully designed multi-layer gamma energy filters, H*(10) (deep dose) or H'(0,07) (shallow dose) measurements from 17 - 1300 keV can be performed. The instrument can even be worn in a belt holster, so that the impact to the mobility of the user is minimized. For emergency response purposes alpha and beta contamination can be discriminated using another optional filter; a simple sample changer adapter can extend the scope of application. Immediate and reproducible counter measurements, e.g. of smear tests can be performed locally. (author)